R. Pullmann et al., Cytotoxic T lymphocyte antigen 4 (CTLA-4) dimorphism in patients with systemic lupus erythematosus, CLIN EXP RH, 17(6), 1999, pp. 725-729
Objective
Genetic susceptibility to systemic lupus erythematosus (SLE) is conferred n
ot only by various genes within the major histocompatibility complex (MHC)
region, but also by several other non-MHC linked genes. The negatively sign
alling molecule CTLA-4 is involved in establishing and maintaining of perip
heral T cell tolerance which controls T cell activation and reactivity. Its
attenuating action helps to prevent an inappropriate initiation of T cell
responses to self antigens and to terminate ongoing T cell responses, We te
sted if there was an association between CTLA-4 and SLE, a disease with B a
nd T cell hyperreactivity and impaired peripheral T cell tolerance
Methods
Using the polymerase chain reaction restriction fragment length polymorphis
m method with Bbv I digestion, we assessed an exon I transition dimorphism
(49 A/G) of the CTLA-4 gene in 102 SLE patients and in 76 healthy controls.
Results
The distribution of CTLA -4 exon 1 genotypes in the SLE group was significa
ntly different from that in the controls (chi(2) = 6.178, p < 0.05). 17.6%
of the SLE patients were G/G homozygotes compared to 5.3% of the controls;
36.3% were A/G heterozygotes vs 40.8% of controls; and 46.1% were A/A homoz
ygotes vs 53.9% of the controls. The frequency of the G allele was signific
antly higher in SLE patients (35.8%) than in controls (25.7%; chi(2) = 4.14
2, p = 0.042).
Conclusion
Our results indicate that the non-MHC linked CTLA-4 gene could confer susce
ptibility in SLE, as it does in various other autoimmune diseases (Hashimot
o thyroiditis, Graves' disease, IDDM).